IU Health Pharmacy

Indianapolis, Indiana 46202

0 studies enrolling now · 3 studies all time

What they study most

CD33 Positive Acute Myelogenous Leukemia, Growth Hormone Deficiency, Venous Thromboembolism

Studies at this site

• Apixaban for the Acute Treatment of Venous Thromboembolism in Children — Completed
• Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD — Completed
• Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy — NO_LONGER_AVAILABLE